What is the level of liabilities of Spineway this year?
Spineway has a debt balance of 7.26 M EUR this year.
Spineway Liabilities 2024
Spineway Liabilities
7.26 M EUR
Ticker
ALSPW.PA
ISIN
FR0011398874
WKN
A1KCX1
In 2024, Spineway's total liabilities amounted to 7.26 M EUR, a 27.58% difference from the 5.69 M EUR total liabilities in the previous year.
Spineway Aktienanalyse
What does Spineway do?
Spineway SA is an internationally active company specializing in the development and marketing of innovative solutions in the field of spinal surgery. The company was founded in France in 2005 and has since expanded its business to be present in over 40 countries. The business model of Spineway is based on strong research and development capabilities as well as a close network of partners such as hospitals and surgeons. The goal is to continuously analyze the needs of patients and the challenges of modern spinal surgery and develop innovative solutions that enable doctors to perform their work more precisely and safely. Spineway specializes in three main areas: instrumentation, biomaterials, and spinal health. It offers a wide range of instruments, from screws to implants, that can be used in the lumbar, thoracic, and cervical spine. The company works closely with surgeons to develop specific solutions and instruments that meet the individual needs of patients. In addition, Spineway develops and produces its own biomaterials, which are used in various products such as screws and cages that are implanted in the spine. The company has developed a customized production line to ensure the highest possible quality of its biomaterials. Spineway is also committed to improving spinal health through innovative solutions and patient and physician education. The company has developed various programs to raise awareness among patients about how to maintain and improve the health of their spine. Some of Spineway's most well-known products include spinal surgery solutions such as the Mont-Blanc All-in-One Steering and K-Fix Steering, as well as a wide range of cages and screws made from their own biomaterials. Additionally, Spineway has developed products for the transplantation of cartilage and connective tissue. Over the years, Spineway has achieved several important milestones. The company has been listed on the Paris Stock Exchange since 2011 and has expanded its global presence in recent years through the opening of subsidiaries in the US, Mexico, and Brazil, as well as strategic partnerships in Asia and the Middle East. In summary, Spineway holds a leading position in the spinal surgery market and continues to focus on constantly searching for innovative solutions to maximize returns for its investors and improve the lives of patients. Spineway ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Spineway's Liabilities
Spineway's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Spineway's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Spineway's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Spineway's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Spineway’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Spineway stock
What were the liabilities of Spineway compared to the previous year?
The liabilities of Spineway have increased by 27.58% increased compared to the previous year.
What are the consequences of high debt for investors of Spineway?
High liabilities can pose a risk for investors of Spineway, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Spineway?
Low liabilities mean that Spineway has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Spineway affect the company?
An increase in liabilities of Spineway can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Spineway affect the company?
A decrease in the liabilities of Spineway can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Spineway?
Some factors that can influence the liabilities of Spineway include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Spineway so important for investors?
The liabilities of Spineway are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Spineway take to modify the liabilities?
To change its liabilities, Spineway can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Spineway pay?
Over the past 12 months, Spineway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Spineway is expected to pay a dividend of 0 EUR.
What is the dividend yield of Spineway?
The current dividend yield of Spineway is .
When does Spineway pay dividends?
Spineway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Spineway?
Spineway paid dividends every year for the past 0 years.
What is the dividend of Spineway?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Spineway located?
Spineway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Spineway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spineway from 9/19/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 9/19/2024.
When did Spineway pay the last dividend?
The last dividend was paid out on 9/19/2024.
What was the dividend of Spineway in the year 2023?
In the year 2023, Spineway distributed 0 EUR as dividends.
In which currency does Spineway pay out the dividend?
The dividends of Spineway are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spineway
Our stock analysis for Spineway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spineway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
